- Home
- RAPT vs PFO Comparison
RAPT vs PFO Comparison
Compare RAPT & PFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- PFO
- Stock Information
- Founded
- RAPT 2015
- PFO 1991
- Country
- RAPT United States
- PFO United States
- Employees
- RAPT N/A
- PFO N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- PFO Finance Companies
- Sector
- RAPT Health Care
- PFO Finance
- Exchange
- RAPT Nasdaq
- PFO Nasdaq
- Market Cap
- RAPT 117.5M
- PFO 120.4M
- IPO Year
- RAPT 2019
- PFO N/A
- Fundamental
- Price
- RAPT $0.79
- PFO $8.71
- Analyst Decision
- RAPT Hold
- PFO
- Analyst Count
- RAPT 7
- PFO 0
- Target Price
- RAPT $5.00
- PFO N/A
- AVG Volume (30 Days)
- RAPT 1.1M
- PFO 31.8K
- Earning Date
- RAPT 05-08-2025
- PFO 01-01-0001
- Dividend Yield
- RAPT N/A
- PFO 6.51%
- EPS Growth
- RAPT N/A
- PFO N/A
- EPS
- RAPT N/A
- PFO N/A
- Revenue
- RAPT N/A
- PFO N/A
- Revenue This Year
- RAPT N/A
- PFO N/A
- Revenue Next Year
- RAPT N/A
- PFO N/A
- P/E Ratio
- RAPT N/A
- PFO N/A
- Revenue Growth
- RAPT N/A
- PFO N/A
- 52 Week Low
- RAPT $0.79
- PFO $6.90
- 52 Week High
- RAPT $8.58
- PFO $8.51
- Technical
- Relative Strength Index (RSI)
- RAPT 31.31
- PFO 42.68
- Support Level
- RAPT $0.81
- PFO $8.47
- Resistance Level
- RAPT $0.98
- PFO $8.83
- Average True Range (ATR)
- RAPT 0.10
- PFO 0.23
- MACD
- RAPT -0.03
- PFO -0.02
- Stochastic Oscillator
- RAPT 7.72
- PFO 46.87
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated
Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end management investment company. Its primary investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.